Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/1995
12/05/1995US5472969 Administering N-alkyl-1,5-dideoxy-1,5-imino-D-glucitol
12/05/1995US5472968 Spiro[cycloalkylbenzene-1,1'-(1',2',3',4'-tetrahydro-isoquinolines)] having neuroprotective properties
12/05/1995US5472966 Antidepressant heteroarylaminoalkyl derivatives of naphthyl-monazines
12/05/1995US5472965 Useful for treatment of retrovirus infections; less toxic
12/05/1995US5472964 Diaryl 5,6-fused heterocyclic acids as leukotriene antagonists
12/05/1995US5472962 Antiestrogenic agents
12/05/1995US5472961 Acetamides
12/05/1995US5472959 Hypotensive agents, congestive heart failure
12/05/1995US5472958 2-((nitro)phenoxymethyl) heterocyclic compounds that enhance cognitive function
12/05/1995US5472957 Administering 1-alpha-hydroxy vitamin D3
12/05/1995US5472956 Treating lung, breast, colon, ovaries or melanomas
12/05/1995US5472953 Fractionated heparin for the therapeutic treatment of malaria
12/05/1995US5472949 N4 -(substituted-oxycarbonyl)-5'-deoxy-5-fluorocytidine compounds, compositions and methods of using same
12/05/1995US5472947 Application of 4-carbamoyl-1-β-D-ribofuranosyl imidazolium-5-olate to the treatment of multiple sclerosis
12/05/1995US5472943 Co-administering agonist and antagonist
12/05/1995US5472873 Rhodotorula rubra useful in a process for the preparation of (ω-1)-hydroxyalkylxanthines
12/05/1995US5472863 Trehalose-releasing enzyme
12/05/1995US5472730 γ-aminobutyric acid-enriched food material and method for producing γ-aminobutyric acid
12/05/1995US5472714 Double-layered oxcarbazepine tablets
12/05/1995US5472712 A drug substrate containing an active agent coated with ethyl cellulose being cured at a temperature greater than the glass transition temperature; storage stability, sustained release
12/05/1995US5472707 High dose ranolazine formulations
12/05/1995US5472705 Pharmaceutical composition containing esters of ω-3 polyunsaturated acids and their use in the topical treatment of morbid affections
12/05/1995US5472703 Ophthalmic lens with anti-toxin agent
12/05/1995US5472687 Topical pyridine N-oxides
12/05/1995US5472684 Antibacterial mixture of thymol, eugenol, and/or a sesquiterpene alcohol; mouthwashes, dentifrices; synergistic
12/05/1995US5472002 Cigarette filter for administering taurine by inhalation
12/05/1995CA2012875C Skin permeation enhancer compositions
12/05/1995CA2001194C Use of resiniferatoxin and analogues thereof to cause sensory afferent c-fiber and thermoregulatory desensitization
12/04/1995CA2150517A1 Thieno ¬1,5| benzodiazepine use
12/04/1995CA2150421A1 Platinum complex and malignant tumor treating drug containing the same
12/03/1995CA2150780A1 Inhibitor of vascular permeability enhancer
12/03/1995CA2150645A1 3-heteroaliphatyl- and 3-hetero(aryl)aliphatyl-2(1h) -quinolone derivatives
12/02/1995CA2127762A1 Extracts from piliostigma thonningii, the use thereof and formulations containing them
12/01/1995CA2150442A1 Cefixime composition
12/01/1995CA2150305A1 Heterocyclylcarbonyl substituted benzofuranyl- and -thiophenyl-alkanecarboxyclic acid derivatives
12/01/1995CA2150304A1 Thermal granulation process
12/01/1995CA2150301A1 Oxalylamino-benzofuran-and benzothienyl-derivatives
12/01/1995CA2150300A1 Amino-benzofuryl- and thienyl-derivatives
11/1995
11/30/1995WO1995032309A1 Treatment of influenza virus infection using antivirals that inhibit acylation/palmitylation of hemagglutinin
11/30/1995WO1995032298A2 Safe vectors for gene therapy
11/30/1995WO1995032282A1 Interleukin-6 splice variant
11/30/1995WO1995032269A1 Low foam sanitizers
11/30/1995WO1995032213A1 Oligonucleotides with anti-cytomegalovirus activity
11/30/1995WO1995032210A1 Cephalosporin compounds and processes for the preparation thereof
11/30/1995WO1995032209A1 AZABICYCLOALKYL DERIVATIVES OF IMIDAZO(1,5-a)INDOL-3-ONE AS 5HT3 ANTAGONISTS
11/30/1995WO1995032208A1 IMIDAZOLYLALKYL DERIVATIVES OF IMIDAZOL(5,1-c)(1,4)BENZOXAZIN-1-ONE AND THEIR USE AS THERAPEUTIC AGENTS
11/30/1995WO1995032205A1 Tricyclic dicarbonyl derivatives
11/30/1995WO1995032204A1 Imidazolylalkyl derivatives of imidazo(1,5-a)indol-3-one and their use as therapeutic agents
11/30/1995WO1995032203A2 Use of tetrahydropteridine derivatives as no-synthase inhibitors
11/30/1995WO1995032200A1 Oxathiolanes, method for their preparation and pharmaceutical compositions containing same
11/30/1995WO1995032198A1 Imidazole derivatives and processes for the preparation thereof
11/30/1995WO1995032197A1 Palladium catalyzed ring closure of triazolyl tryptamine
11/30/1995WO1995032196A1 Piperazine, piperidine and tetrahydropyridine derivatives of indol-3-ylalkyl as 5-ht1d-alpha agonists
11/30/1995WO1995032194A1 Synthesis of optically pure 4-alkenyl- or 4-alkanyl-2-hydroxytetronic acids
11/30/1995WO1995032191A1 Inhibitors of farnesyl-protein transferase
11/30/1995WO1995032190A2 Pharmaceutical diketopiperazine compounds
11/30/1995WO1995032187A1 Novel fused indan derivative and pharmaceutically acceptable salt thereof
11/30/1995WO1995032185A1 N-(3-amino-2-hydroxybutyl)sulphonamide derivatives as hiv protease inhibitors
11/30/1995WO1995032175A1 Di-tert-butylphenol compounds useful as anti-inflammatory agents
11/30/1995WO1995031995A1 Mimetics of senescent cell derived inhibitors of dna synthesis
11/30/1995WO1995031991A2 Use of magnesium-based products for the treatment or prophylaxis of neoplastic and autoimmune diseases
11/30/1995WO1995031990A1 Copolymer-1 improvements in compositions of copolymers
11/30/1995WO1995031988A1 COMPOSITION CONTAINING 5HTIA and 5HTID ANTAGONISTS
11/30/1995WO1995031987A1 Use of pteridine derivatives as no-synthase inhibitors
11/30/1995WO1995031986A1 Combination product of dichloroacetic acid and an nmda antagonist
11/30/1995WO1995031985A2 Pharmaceutical compositions comprising an opiate antagonist and calcium salts, their use for the treatment of endorphin-mediated pathologies
11/30/1995WO1995031983A1 Treating conditions with (+)-liarozole
11/30/1995WO1995031982A1 Treating conditions using optically pure(-)-liarozole
11/30/1995WO1995031981A2 Methods and compositions for reducing multidrug resistance
11/30/1995WO1995031980A1 Applying alpha hydroxy acids for striae distensae
11/30/1995WO1995031979A1 Solutions of aryl or heteroaryl substituted alkanoic acids in lipophilic solvents and soft gelatin capsules containing such solutions
11/30/1995WO1995031978A1 Anti-acne compositions
11/30/1995WO1995031977A1 Novel potent inducers of terminal differentiation and methods of use thereof
11/30/1995WO1995031976A1 Transdermal delivery of anti-epileptic drugs
11/30/1995WO1995031973A1 Continuous method of grinding pharmaceutical substances
11/30/1995WO1995031972A1 Powder-layered oral dosage forms
11/30/1995WO1995031971A1 Method for stabilizing duocarmycin derivatives
11/30/1995WO1995031968A1 Non-steroidal anti-inflammatory ophthalmic suspensions
11/30/1995WO1995031966A1 Antimicrobial oil-in-water emulsions
11/30/1995WO1995031965A1 Physiologically acceptable emulsions containing perfluorocarbon ether hydrides and methods of use
11/30/1995WO1995031964A1 Fluticasone propionate formulations
11/30/1995WO1995031963A1 Chewable flubendazole tablets for companion animals
11/30/1995WO1995031958A1 Disinfectants and sanitizers with reduced eye irritation potential
11/30/1995WO1995031956A1 Antibacterial oil-in-water emulsions
11/30/1995WO1995031902A1 Predicting fetal membrane rupture by mmp-9 activity
11/30/1995DE4418097A1 Verwendung von Tetrahydropteridin-Derivaten als Hemmstoffe der NO-Synthase Using Tetrahydropteridin derivatives as inhibitors of NO synthase
11/30/1995DE4418096A1 Verwendung von Pteridin-Derivaten als Hemmstoffe der NO-Synthase The use of pteridine derivatives as inhibitors of NO synthase
11/30/1995DE4415263C1 Cis-[trans-1,2-Cyclobutanbis(methylamin)-N,N']-[(2S)-lactato-O·1·, O·2·]-platin(II)-trihydrat (Lobaplatin-Trihydrat), seine Herstellung und arzneiliche Verwendung Cis- [trans-1,2-Cyclobutanbis (methylamine) -N, N '] - [(2S) -lactato-O · 1 ·, O · 2 ·] -platinum (II) trihydrate (lobaplatin trihydrate), its preparation and medicinal use
11/30/1995CA2574103A1 Novel potent inducers of terminal differentiation and methods of use thereof
11/30/1995CA2191191A1 Oligonucleotides with anti-cytomegalovirus activity
11/30/1995CA2190846A1 Inhibitors of farnesyl-protein transferase
11/30/1995CA2190839A1 Disinfectants and sanitizers with reduced eye irritation potential
11/30/1995CA2190763A1 Fluticasone propionate formulations
11/30/1995CA2190636A1 Methods and compositions for reducing multidrug resistance
11/30/1995CA2190635A1 Method for stabilizing duocarmycin derivatives
11/30/1995CA2190606A1 Antimicrobial oil-in-water emulsions
11/30/1995CA2190604A1 Antibacterial oil-in-water emulsions
11/30/1995CA2190581A1 Treatment of influenza virus infection using antivirals that inhibit acylation/palmitylation of hemagglutinin
11/30/1995CA2190501A1 Piperazine, piperidine and tetrahydropyridine derivatives of indol-3-ylalkyl as 5-ht1d-alpha agonists
11/30/1995CA2190472A1 N-(3-amino-2-hydroxybutyl)sulphonamide derivatives as hiv protease inhibitors
1 ... 6963 6964 6965 6966 6967 6968 6969 6970 6971 6972 6973 6974 6975 6976 6977 6978 6979 6980 6981 6982 6983 ... 7860